{"id":1657,"date":"2022-01-14T04:30:46","date_gmt":"2022-01-13T21:30:46","guid":{"rendered":"https:\/\/udibi6748.live-website.com\/news\/"},"modified":"2024-10-17T09:27:51","modified_gmt":"2024-10-17T15:27:51","slug":"news","status":"publish","type":"page","link":"https:\/\/udibi.com.mx\/en\/news\/","title":{"rendered":"News"},"content":{"rendered":"

[vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_custom_heading text=”News” font_container=”tag:h2|font_size:35|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1638395476420{margin-top: 1px !important;padding-top: 10px !important;}”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”4058″ img_size=”720×720″ alignment=”center” css=”” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”UDIBI at the Festival of Biologics 2024, Basel Switzerland” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=””][vc_column_text css=””]On October 16, Dr. Juan Carlos Almagro, Director of Antibody Research at UDIBI, participated in the \u201cFestival of Biologics 2024\u201d in Basel, Switzerland. This event gathered international experts to advance the development of innovative biological therapies.<\/p>\n

During his presentation, Dr. Almagro highlighted the antibody discovery platforms developed in Mexico and the key advancements stemming from them. He also successfully led the roundtable discussion on bispecific antibodies and the session on \u201ccheckpoint inhibitors\u201d. These accomplishments reflect the hard work and dedication of the UDIBI team at IPN, showcasing Mexico\u2019s capability to conduct top-tier research and development.<\/p>\n

The \u201cFestival of Biologics\u201d serves as a vital platform that connects industry, academia, and biotechnology to tackle challenges in the biopharmaceutical sector. Dr. Almagro\u2019s participation underscores UDIBI\u2019s commitment to driving scientific innovation and placing Mexico on the global biotechnology map.<\/p>\n

Proudly polytechnic, proudly UDIBI, 100% Mexican![\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”4046″ img_size=”720×720″ alignment=”center” css=”” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”UDIBI at TechPharmaNet 2024″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=””][vc_column_text css=””]On October 2-3, UDIBI proudly participated in the TechPharmaNet, event held at the Marquis Reforma Hotel in Mexico City. This prestigious event brought together executives and experts from across the pharmaceutical industry, creating a platform for sharing knowledge and forging valuable professional connections in the areas of research, development, and commercialization.<\/p>\n

Dr. Sonia Mayra P\u00e9rez-Tapia, our Director, delivered an insightful presentation showcasing UDIBI\u2019s strengths in technology, infrastructure, and regulatory compliance. She also highlighted the groundbreaking progress in the development of therapeutic antibodies. One of our key achievements is the creation of a fully Mexican-developed, innovative antibody from our own libraries, which has shown promising results in eradicating tumors in non-clinical models. This antibody is now set to be transferred to a national pharmaceutical company for further development, positioning UDIBI as a leader in the creation of advanced biotechnological products aimed at treating various diseases, including cancer.<\/p>\n

TechPharmaNet 2024 served as a vital opportunity for fostering collaboration and growth between the pharmaceutical and biotech sectors, reaffirming UDIBI\u2019s commitment to advancing research and developing new therapies that will contribute to better global health outcomes.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”4022″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”COFEPRIS endorses authorization extension to UDIBI for the assessment of Biosimilarity through 2026″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On July 2nd<\/sup> the Federal Commission for the Protection against Sanitary Risks of Mexico (COFEPRIS) granted UDIBI the extension of its authorization as a laboratory for the assessment of Preclinical Biosimilarity, valid through July 2026. Since it complied with the provisions of the legal framework required for the authorization of third-party laboratories of COFEPRIS. UDIBI was first authorized to conduct biosimilarity tests on 2015, and from 2017 to date has maintained its authorization as a Third-party laboratory for the assessment of Preclinical Biosimilarity, in compliance of the current regulatory and legal framework. Recently, on March 4th<\/sup>, 2024, UDIBI obtained a License that authorizes it as a Testing and Control Laboratory auxiliary to health regulation (Health License: 09 011 13 0002) which along with its authorization as a \u201cThird-party Test Laboratory\u201d which has been in effect since 2017, allows UDIBI to have a broad analytical framework to carry out physicochemical, microbiological, biological and immunological analyzes to evaluate medicines, medical devices and other health supplies.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”4004″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”UDIBI Present at \u201cBIO international Convention 2024\u201d in San Diego, California.” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Mexico participated in the Bio International Convention 2024, from June 3 to 6 in San Diego California, thanks to the support of the Ministry of Foreign Affairs (SRE) and the Mexican Consulate in San Diego, California,<\/p>\n

BIO is one of the most important conventions worldwide in promoting innovation, research and attracting investments in the field of biotechnology.<\/p>\n

Around 21,000 participants from more than 60 countries gathered for this edition. The Mexican delegation was represented by important institutes and companies of the biotechnology sector such as Cecype, Epic-CRO, Incide, Pisa Pharmaceutical, New Genesis, Organon, Pragmatec , Network of Technology Transfer Offices, Tijuana Economic Development Corporation, Udel\u00e1 and UDIBI.<\/p>\n

UDIBI\u2019s Directors; Dr Sonia Mayra P\u00e9rez Tapia and Dr. Juan Carlos Almagro, and Business Development Manager; Dr. Sergio Torres P\u00e9rez, attended this important convention to show the capabilities of UDIBI and establish new collaboration opportunities with biopharmaceutical companies in the world.<\/p>\n

Mexico’s presence at the convention places it as a relevant and strategic player in the global biotechnology panorama, since numerous biotechnology companies, academic institutions and cutting-edge research centers have been developed in our country, which ranked it as one of the three most important countries in Latin America in this industry, as the result of the collaboration between the public and private sectors and academia.<\/p>\n

Related notes:
\nhttps:\/\/www.gob.mx\/sre\/prensa\/mexico-participa-en-la-bio-international-convention-2024?tab=<\/a><\/p>\n

https:\/\/www.excelsior.com.mx\/nacional\/industria-farmaceutica-mexicana-bio-international-convention-2024\/1656130<\/a>).[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3966″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Meeting of Innovative Professors of the IPN” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On Wednesday, December 6, 2023, Dr. Perez Tapia participated in the meeting of
\nInnovative Professors of the IPN, where she presented the talk entitled &quot;Innovation and
\nTechnological Developments in Health from the IPN, thereby showing that in the UDIBI we
\ntake biotechnological innovation in Mexico to the next level.
\nWatch the video in: https:\/\/www.youtube.com\/watch?v=kN5MM6xA9zI<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3943″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”18th International Congress of Immunology” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]At UDIBI we are proud that our graduate students in Immunology, Ivette Mendoza and Ismael Trejo, attended to the “18th International Congress of Immunology” in Cape Town, South Africa, we celebrate these enriching international experiences and we are sure that they put up “The technology at the service of our homeland”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3946″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Cycle of talks on Biotechnology \/ Biopharmaceuticals” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On Tuesday, November 28th, Dr. Sonia Mayra Perez Tapia attended to the ” Cycle of talks on Biotechnology \/ Biopharmaceuticals\u201d, talking about: “Biosimilars source of innovation in Mexico”, where she shared details about the innovation model of the UDIBI.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3941″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Sanitary regulation applicable to hemoderivative drugs.” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On November 28, 2023, our collaborator, Dr. Carlos Lopez, gave a talk on “Hemoderivatives: Basic concepts” in the course “Sanitary regulation applicable to hemoderivative medicines” of AMEPRES.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3938″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Symposium “Spectral Cytometry“” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]M. en C. Alejandra Montes, collaborator of UDIBI, was present at the symposium “Spectral Cytometry”, at the Universidad Distrital de Colombia, where she shared about the importance of the flow cytometer in the research and development of therapeutic antibodies.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3935″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Quality and regulatory aspects for clinical trials focused on biotherapeutics” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On November 24, Dr. Sonia Mayra Perez Tapia was present at the facilities of the Tecnologico de Monterrey campus CDMX where she presented a talk entitled “Quality and regulatory aspects for clinical trials focused on biotherapeutics”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3932″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”29th Anniversary Academic Conference of the Hospital del Ni\u00f1o Morelense” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Last Friday, November 24, Dr. Sonia Mayra Perez Tapia was present at the “29th Anniversary Academic Conference of the Hospital del Ni\u00f1o Morelense”, with the theme: “Realities of the transfer factor”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3930″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Transferon Oral\u00ae” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Transferon Oral\u00ae is an outstanding contribution of the National Polytechnic Institute, which has had an impact on the health of thousands of people with immunological diseases at a national and international level. It has a patent registration in favor of the IPN in Mexico and 36 other countries, including the United States, Canada and the European Union.<\/p>\n

Read more in https:\/\/www.ipn.mx\/…\/gaceta…\/2023\/08\/g-60-aniv-1739.pdf<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3927″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”CANIFARMA 2023 Award” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]UDIBI-IPN, extends congratulations to Dr. Aliesha Araceli Gonzalez Arenas from the Institute of Biomedical Research of the UNAM, for winning first place in the “CANIFARMA 2023 Award” in the category of Clinical Research.<\/p>\n

Congratulations![\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3925″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”8th International Meeting on Health Regulation” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Dr. Mayra Perez Tapia participated in the “8th International Meeting on Health Regulation”, with the presentation “Regulatory Overview of Biotechnological and Biosimilar Medicines in LATAM”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3922″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Biosimilars LatAm Mexico 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On November 15, Dr. Mayra Perez Tapia was at Biosimilars LatAm Mexico 2023, where she shared important points about the construction of the future of Biosimilars in Mexico and LatAm through academia.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3920″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”International Collaboration” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]An enriching visit to the UDIBI-ENCB-IPN of the Instituto Nacional de Cancerolog\u00eda-ESE of Colombia, where we explored our capabilities and outlined exciting routes of collaboration to advance research and new technologies in the fight against cancer.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3917″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”LVI National, X International and IV Virtual Congress of Pharmaceutical Sciences” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From November 6 to 8, we were present at the “LVI National, X International and IV Virtual Congress of Pharmaceutical Sciences”, showing our capabilities, technologies and services.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3915″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Mexico on the cover of Nature with Huichol indigenous art” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]The work of researcher Andr\u00e9s Moreno-Estrada and his team from the Mexican Biobank Project was presented. By genotyping 6,057 individuals from all 32 Mexican states, they ensured representation from indigenous communities. In addition, Jonathan Marchini and colleagues share results from the Mexico City Prospective Study, which genotyped and sequenced 140,000 adults in two districts of the capital. Together, these papers reveal the genetic histories of the Mexican population and offer insights into genetic risks associated with disease. #MexicanGenomics #ScientificResearch.<\/p>\n

Comment: https:\/\/www.nature.com\/nature\/volumes\/622\/issues\/7984<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3913″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”International Book and Reading Festival San Lorenzo Tezonco” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On October 26, 2023, Dr. Mayra Perez Tapia was present at the “Festival Internacional del Libro y la Lectura San Lorenzo Tezonco”, with the theme “Women, Science and Entrepreneurship: Inspiring the Future”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3911″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”44th Pediatrics Update Meeting” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On October 26, 2023, Dr. Sonia Mayra Perez Tapia was present at the “44th Update Meeting in Pediatrics”, with the topic:<\/p>\n

“Immunomodulation with Transfer Factor (Transferon Oral \u00ae) in Allergic diseases”.<\/p>\n

\u00a0<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3909″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”50 years of DNA Recombinant Technology: Its impact on human biology, medicine, laboratory and pharmacy” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On October 25, 2023, Dr. Mayra Perez Tapia participated in the Symposium “50 years of DNA Recombinant Technology: Its impact on human biology, medicine, laboratory and pharmacy”, which was held at the National Academy of Medicine of Mexico with the theme “From gene to cell therapy”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3903″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XII Annual Congress of RedOTT Mexico” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From October 18 to 20, UDIBI was present at the “XII Annual Congress of RedOTT Mexico” in the city of Irapuato, Guanajuato, where we showed that at UDIBI we take biotechnological innovation in Mexico to the next level.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3869″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Antiverse and GlobalBio extend checkpoint inhibitor collaboration” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Our strategic partner GlobalBio extends the agreement with the antibody engineering company Antiverse, for the development of checkpoints inhibitors in cancer, with two anti-PD1 antibodies in preclinical development.<\/p>\n

Read more: https:\/\/ow.ly\/J2Fz50PYQ4N<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3864″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XIII National Congress of Virology” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From October 5 to 7, 2023, in Oaxaca, Mexico; UDIBI was present at the “XIII National Congress of Virology”, organized by the Mexican Society of Virology, where we participated in different activities such as sponsors, presentation of oral papers and posters, thus showing that in UDIBI we take biotechnological innovation in Mexico to the next level.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3862″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Second IPN 2023 Innovaxion Fair” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From October 4 to 5, 2023 UDIBI-IPN was present at the “Second edition of the IPN Innovation Fair”, where we showed the technology and innovation of our products and services.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3827″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”BIOSPAIN” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From September 26th to 28th, 2023 UDIBI-IPN was present at BIOSPAIN 2023, the most important biotechnology forum in Europe, where we showed our capabilities, technologies and services.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3830″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XXVII ANIVERSARIO DEL CENTRO DE INVESTIGACI\u00d3N EN CIENCIA APLICADA Y TECNOLOG\u00cdA AVANZADA UNIDAD LEGARIA (CICATA LEGARIA)” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On September 22, Dr. Sonia Mayra Perez Tapia participated in the round table “Health in Mexico” where she shared her knowledge and point of view on the subject.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3833″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XX National Congress of Biotechnology and Bioengineering” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On September 14, Dr. Sonia Mayra Perez Tapia participated in the symposium “COVID-19” of the “XX National Congress of Biotechnology and Bioengineering” with the topic “Isolation, optimization and preclinical development of a broad spectrum neutralizing anti-SARS-CoV2 antibody”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3836″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XX National Congress of Biotechnology and Bioengineering” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From September 11 to 15, 2023, in Ixtapa Zihuatanejo, UDIBI was present at the “XX National Congress of Biotechnology and Bioengineering”, organized by the Mexican Society of Biotechnology and Bioengineering, where we participated in different activities such as sponsors, presentation of oral papers and in the symposium entitled “COVID-19″.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3839″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Biosimilars LatAm \u2013 Europe 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On September 13, Dr. Sonia Mayra P\u00e9rez Tapia participated in Biosimilars LatAm – Europe 2023, with the talk “Similarity: a source of innovation in Mexico”, where she shared her knowledge, contributions and point of view about biosimilars in our country.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3842″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XL International Book Fair of the National Polytechnic Institute with the presentation” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On September 5, Ignacio Mejia Calvo, UDIBI Services Manager, participated in the XL International Book Fair of the National Polytechnic Institute with the presentation “COVID-19, an opportunity for innovation in the IPN”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3845″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”EL ECONOMISTA” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Last Monday, August 28th, Dr. Mayra Perez Tapia participated in the article “Opinion: Biotechnology dependence or self-sufficiency”, for EL ECONOMISTA, where she commented on the basic premises towards self-sufficiency in biotechnology-based medicine. To read the article click here<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3848″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Biosimilars LatAm – Brazil 2023, with the talk” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On August 16, Dr. Sonia Mayra P\u00e9rez Tapia participated in Biosimilars LatAm – Brazil 2023, with the talk “Similarity: a source of innovation in Mexico”, where she shared her knowledge, contributions and point of view about biosimilars in our country.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3704″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”1st Latin American Forum on Advanced Therapies” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Last Friday, August 4, Dr. Sonia Mayra Perez Tapia participated in the “1st Latin American Forum on Advanced Therapies” where she shared knowledge about the “Challenges in clinical trials for the regulation of advanced therapies”, if you missed it click here https:\/\/ow.ly\/WLJ450PmaHQ<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3701″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Myths and realities of post-COVID sequels” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On July 13, 2023 Dr. Mayra Perez Tapia was present in the radio program “La Mujer Actual con Janett Arceo” where she shared relevant information about the “Myths and realities of post-COVID sequels”, if you missed it click here https:\/\/www.youtube.com\/watch?v=fci-16elotM<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3389″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XXX COMPEDIA Congress” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Last Saturday, July 8, Dr. Sonia Mayra Perez Tapia participated in the “XXX COMPEDIA Congress” where she shared the latest advances in the research and development of our product Transferon Oral\u00ae, a proudly polytechnic product![\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3387″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Congress of Health Regulation Professionals” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On July 5, Dr. Sonia Mayra Perez Tapia was present at the inauguration of the Tenth National Congress of Health Regulation Professionals, an event presided by the Head of the Ministry of Health in Guerrero, Aib\u00e9 Ibarez Castro.<\/p>\n

More information at https:\/\/guerrero.quadratin.com.mx\/inaugura-aide-ibarez…\/<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3053″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Flavors and fragrances at IPN” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On June 22nd, Dr. Sonia Mayra P\u00e9rez Tapia was interviewed in the program \u00a1Hu\u00e9lum!- Flavors and Fragrances of the IPN, where she talked about the characterization of Transferon (Transfer Factor), you can see the transmission here.<\/p>\n

https:\/\/www.youtube.com\/watch?v=D4fVYMgicwY<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3056″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”INNOVAPRIS “ADVANCED THERAPY MEDICINAL PRODUCTS“.” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Last June 22, 2023 Dr. Sonia Mayra Perez Tapia participated in the InnovaPRIS session “Advanced Therapy Medicinal Products”, which seeks to exchange ideas and experiences to improve the welfare of the population by giving visibility to innovative practices in regulated industries.<\/p>\n

To watch the transmission click on \u00a0https:\/\/ow.ly\/ACEI50OYoiT<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3075″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”INNOVATIBLES “INTELLECTUAL PROPERTY, INNOVATION AND SCIENCE“.” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Listen to the seventh episode of FIFARMA’s podcast #Innovatibles!<\/p>\n

In the episode, Yaneth Giha, Executive Director of FIFARMA and Sonia Mayra Perez Tapia, Executive Director of UDIMEB and recognized innovator expert in immunology, talk about the importance of Intellectual Property as the basis to boost innovation and development in Latin America.<\/p>\n

???? Listen here and share this podcast so that more people can explore Latin American talents and knowledge.<\/p>\n

????Spotify: https:\/\/ow.ly\/IKZn50OOJkp<\/a><\/p>\n

????Apple: https:\/\/ow.ly\/ges550OOJki<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3078″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”BIO International Convention 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From June 5 to 8, UDIBI was present at the most important biotechnology convention in the world, “BIO International Convention 2023″ in the city of Boston. This event was attended by more than 14,000 people from industry, academia and government representatives from countries with important advances in biotechnology, including Mexico. UDIBI connected with the global ecosystem of the biotech industry, associations, educational institutions and investors, creating great collaborations for the future.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3081″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XXV NATIONAL CONGRESS OF IMMUNOLOGY” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From June 4 to 8, 2023, in the city of Santiago de Queretaro, Queretaro, UDIBI was present at the “XXV National Congress of Immunology”, organized by the Mexican Society of Immunology, where we participated in different activities such as sponsors, poster presentations, oral presentations and the symposium entitled “Innovation and Technological Development”, which was attended by international speakers.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3096″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”LXXVII Congress “CMICA“ Mexican College of Clinical Immunology and Allergy A.C. 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Last Saturday June 3rd in Guadalajara, Jalisco, Dr. Sonia Mayra Perez Tapia was present at the Congress of the Mexican College of Clinical Immunology and Allergy A.C. where she spoke on the topic “Immunomodulation with Transfer Factor (Transferon Oral \u00ae) and Allergic Diseases”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3085″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”FIRST DAY OF PROJECTS OF THE “TECHNOLOGICAL POSTGRADUATE COURSE IN VACCINES AND BIOTHERAPEUTICS“.” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On May 31, 2023, in the Auditorium of the Interdisciplinary Professional Unit of Biotechnology of the National Polytechnic Institute (UPIBI-IPN), took place the first day of projects of the “Technological Postgraduate in Vaccines and Biotherapeutics”, with the participation of Dr. Sonia Mayra Perez Tapia and collaborators of the UDIBI, see the transmission in the link https:\/\/www.youtube.com\/watch?v=GNN8izf2qb4<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3088″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”1st Oncology Symposium 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On May 25, 2023, Dr. Sonia Mayra Perez Tapia participated in the 1st Symposium on Oncology 2023 at the Hospital Infantil de Mexico Federico Gomez.<\/p>\n

1st Symposium of Oncology 2023 at the Children’s Hospital of Mexico Federico Gomez, with the topic “Platforms for the development of cancer therapies in Mexico”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”3090″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”VIRTUAL SYMPOSIUM ON MONOCLONAL ANTIBODIES THERAPEUTICS” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On May 22, Dr. Sonia Mayra Perez Tapia participated in the virtual symposium of the Mexican Pharmaceutical Association, with the presentation “The future of MABs; therapeutics developing research platforms”.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2832″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”PEGS BOSTON” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Therapy Summit (PEGS) in Boston. The world\u2019s largest gathering of protein engineering and biotherapeutics experts, event with comprehensive programming that covered all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and other interesting topics of biotherapeutics.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2829″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”WHO DECREES END OF COVID-19 EMERGENCY” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]April 19th<\/sup>, 2023. After over three years in which the pandemic caused by the SARS-CoV-2 coronavirus made it necessary to impose restrictions worldwide in order to prevent contagion. The Director General of the World Health Organization, transmitted the report of the International Health Regulations Emergency Committee that determined that COVID-19 is no longer a health emergency.<\/p>\n

view more<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2827″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”BIOSIMILARS LATAM – BOGOT\u00c1 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On April 26th<\/sup>, the Biosimilars LatAm forum, hosted by the Jack Leckerman Company, was held in Bogota, Colombia. UDIBI participated in this forum with the talk on the success story: UDIBI as a link between academia, industry and regulation, talk given by our Service Manager, QFB. Ignacio Mej\u00eda Calvo.<\/p>\n

view more<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2824″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”SECOND NATIONAL WEEK AGAINST SANITARY RISKS 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]From April 24th<\/sup> to 29th<\/sup>, the Second National Week against Sanitary Risks was held in Acapulco, Mexico. In this forum our Director, Dr. Sonia Mayra Perez Tapia participated as moderator of the panel: “The art of regulation as a way to access to new treatments”.<\/p>\n

view more<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2822″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”CONACYT FRONTIER SCIENCE 2023″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On April 18th<\/sup>, the results of the CONACYT’s Frontier Science 2023 call were announced, in which the research proposal “Assessment of immunomodulatory effects of oral extracellular monomeric Ubiquitin (Ubme) in allergic rhinitis: efficacy and pharmacokinetics”, developed by our research group for Immunomodulators led by Dr. Luis Alberto Vallejo Castillo, was awarded. CONGRATULATIONS!<\/p>\n

view more<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2819″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”EXHIBITION OF INNOVATION AND LATIN AMERICAN PATENTS – SRE” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]On March 15th<\/sup>, UDIBI attended to “Latin American Innovation and Patents Exhibition” hosted by the Ministry of Foreign Affairs, the Mexican Agency for International Development Cooperation (AMEXCID) and the Network of Technology Transfer Offices, Mexico (redOTT). This event was held as part of the Science and Technology for Society Forum 2023, on its Latin America and Caribbean Chapter.<\/p>\n

view more<\/a><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2815″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”MEXICO-INDIA AGREEMENT FOR CAR-T CELL THERAPIES” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Duirng the first week of March, our General Director, Dr. Sonia Mayra Perez Tapia, participated as part of the retinue of scientists and diplomats who accompanied the Minister of Foreign Affairs; Marcelo Ebrard on his work tour to ImmunoACT Laboratories in Mumbai, India. The aim of this visit was to follow up on the agreement signed on November 8th, 2022 among the National Institute of Medical Sciences and Nutrition “Salvador Zubir\u00e1n” (INCMNSZ), the National Polytechnic Institute (IPN), and ImmunoACT, intended to promote technology transfer CAR-T (Chimeric Antigen Receptor) cell therapies for the treatment of cancer patients from India to Mexico. CAR-T cell therapy consists in obtaining cells from the patient’s immune system (T lymphocytes) to be genetically modified at the laboratory to make them capable to recognize and fight cancer cells; once modified, the cells (CAR-T) will be administered back to the patient to fight the disease.<\/p>\n

view more<\/a><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2809″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”INTERVIEW WITH DR. SONIA MAYRA PEREZ TAPIA \u2013 \u201cFACTOR CIENCIA\u201d” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]What did we learn from the pandemic?<\/p>\n

view interview<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2297″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”BIO 2022″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Jun 20, 2022<\/p>\n

The UDIBI-IPN present at the Mexico stand with cutting-edge biotechnological developments and products at #BIO2022.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2290″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Symposium CMICA 2022″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Jun 03, 2022<\/p>\n

Lecture by Dr. Sonia Mayra P\u00e9rez Tapia, on the Use of Leukocyte Extracts in Allergic Diseases.
\nDate: June 03
\nLocation: Monterrey, Nuevo Leon
\nRegistration:\u00a0https:\/\/cmica.bycri.com\/registration\/<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2288″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Transferon Oral – Leukocyte Dialyzable Extract” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Jun 02, 2022<\/p>\n

Participation of Dr. Sonia Mayra P\u00e9rez Tapia, in the Academic Session of the
\nNational Congress of the Mexican College of Clinical Immunology and Allergy.[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2282″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Entrepreneurial Women” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]May 23, 2022<\/p>\n

Participation of Dr. Sonia Mayra P\u00e9rez, in the Digital program with Roc\u00edo Braujer, where she discussed her experience as a businesswoman and the obstacles that came her way in her technological-scientific career.<\/p>\n

Link to the video:\u00a0https:\/\/youtu.be\/w7veJnaw5U8<\/a><\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2280″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Science Factor – Transferon: Regulator of the Immune System” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]May 17, 2022<\/p>\n

Participation of Dr. Sonia Mayra P\u00e9rez Tapia, in the Science Factor program, where she shared with us the journey through the research has gone through to carry out the transfer factor, and to remind us of the importance of education in science, technology and innovation in Mexico.<\/b><\/p>\n

Link to the video:\u00a0https:\/\/youtu.be\/9m-caUVlqx0<\/a><\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”2060″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Participaci\u00f3n de la UDIBI en el encuentro PRONAII del 25 y 26 de marzo” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Marzo 08 del 2022<\/p>\n

Participaci\u00f3n de la UDIBI en el encuentro PRONAII del 25 y 26 de marzo de inmunoterapia multidisciplinaria y Leucemia infantil en el Centro de Educaci\u00f3n Cont\u00ednua Ing. Eugenio M\u00e9ndez Docurro de la CDMX[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”1972″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Desarrolla IPN plataformas tecnol\u00f3gicas para hacer frente a las variantes de preocupaci\u00f3n (VOCS)” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Febrero 15 del 2022<\/p>\n

Dr. Mayra P\u00e9rez Tapia, Directora Ejecutiva de UDIBI, Inmun\u00f3loga ENCB.<\/p>\n

Fecha: 17 de febrero<\/p>\n

Hora: 12:00 am<\/p>\n

Reflexi\u00f3n 24 informativo con Esa\u00fa N\u00e1jera.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”1652″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Interview with Dr. Sonia Mayra P\u00e9rez Tapia, CEO of UDIBI” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]January 13, 2022<\/p>\n

Interview with Dr. Sonia Mayra P\u00e9rez Tapia, CEO of UDIBI: Beginning of the development and preclinical evaluation of a mixture of recombinant antibodies against all variants of concern, including the Wuhan, Delta and importantly, against the Omicron variant.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”1654″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Interview with Dr. Juan Carlos Almagro, director of R&d at UDIBI” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]January 13, 2022<\/p>\n

Interview with Dr. Juan Carlos Almagro, director of R&d at UDIBI. He shared on N+Live of Noticieros Televisa, the beginning of a preclinical development and evaluation of recombinant antibodies against all variants of concern, including Wuhan, Delta and, importantly, against the Omicron variant.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”1176″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”D\u00cdA DEL QU\u00cdMICO FARMAC\u00c9UTICO” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Diciembre 01 del 2021<\/p>\n

En UDIBI nos unimos a la celebraci\u00f3n del D\u00eda del Qu\u00edmico Farmac\u00e9utico. Muchas felicidades.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”1045″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”LA BIOTECNOLOG\u00cdA EN LA DETECCI\u00d3N DEL VIRUS SARS-CoV-2″ font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Noviembre 24 del 2021<\/p>\n

LA BIOTECNOLOG\u00cdA EN LA DETECCI\u00d3N DEL VIRUS SARS-CoV-2: logros y perspectivas futuras, el 24 de noviembre en de 2021 en el foro 7 del instituto de qu\u00edmica de la UNAM. Comentarios a cargo de la Dra. Sonia Mayra P\u00e9rez Tapia<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”1010″ img_size=”720×720″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”La importancia del monitoreo de la inmunidad contra SARS-CoV-2 para un regreso seguro a las actividades” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Noviembre 17 del 2021<\/p>\n

Conferencia magistral \u201cLa importancia del monitoreo de la inmunidad contra SARS-CoV-2 para un regreso seguro a las actividades<\/strong>\u201d llevada a cabo el 17 de noviembre del 2021 por la Dra. Sonia Mayra P\u00e9rez Tapia.<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”943″ img_size=”720×480″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Transferencia de Tecnolog\u00eda, Innovaci\u00f3n y Desarrollo” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Noviembre 17 del 2021<\/p>\n

Ponencia con t\u00edtulo \u201cTransferencia de Tecnolog\u00eda, Innovaci\u00f3n y Desarrollo\u201d. A cargo de la Dra. Sonia Mayra P\u00e9rez Tapia. Se llev\u00f3 a cabo el 17 de noviembre en la Ciudad de M\u00e9xico a las 14:50 hora de M\u00e9xico.<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”941″ img_size=”720×480″ alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”PEGS EUROPE” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Noviembre 2 al 4 del 2021<\/p>\n

Presentaci\u00f3n de cartel con t\u00edtulo \u201cIsolation and optimization of neutralizing antibodies against SAR-CoV-2 using ALTHEA Gold Plus LibrariesTM <\/sup>. Exposici\u00f3n a cargo del Dr. Juan Carlos Almagro y la Dra. Sonia Mayra P\u00e9rez Tapia la cual se llev\u00f3 a cabo en Barcelona-Espa\u00f1a del 2 al 4 de noviembre.<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”377″ img_size=”full” alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Anticuerpos: Desde su origen hasta su desarrollo como agentes terap\u00e9uticos” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Septiembre 28 del 2020 a Enero 29 del 2021<\/p>\n

Clase online – Impartido por la Dra.Martha Pedraza y Dra.Sonia Mayra P\u00e9rez<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”383″ img_size=”full” alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Congreso Sociedad Mexicana de Inmunolog\u00eda” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Abril 26 al 29 del 2021<\/p>\n

PARTICIPACI\u00d3N INTEGRANTES UDIBI CON POSTERS Y PONENCIAS DRA MAYRA<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”385″ img_size=”full” alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Expofarma” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Abril 22 al 24<\/p>\n

PARTICIPACI\u00d3N CON STAND, WTC, CDMX.<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”390″ img_size=”full” alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”5a Semana de la Innovaci\u00f3n en Salud, AMIIF” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Marzo 26<\/p>\n

Se pospone hasta nuevo aviso<\/p>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”393″ img_size=”full” alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”La hora nacional” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Marzo 8<\/p>\n

Participaci\u00f3n en temas del 8 de marzo<\/h4>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”396″ img_size=”full” alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”XXVIII Congreso de Educaci\u00f3n Qu\u00edmica Farmac\u00e9utica Biol\u00f3gica y a la XXIV Reuni\u00f3n Nacional de Estudiantes de Farmacia” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Febrero 27<\/p>\n

Conferencia de producci\u00f3n de productos biotecnol\u00f3gicos<\/h4>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_separator color=”custom” accent_color=”#a1bf3b”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”399″ img_size=”full” alignment=”center” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”Foro Especialistas en torno al impulso de las mujeres en \u00e1reas STEM” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text]Febrero 17<\/p>\n

Foro Especialistas en torno al impulso de las mujeres en \u00e1reas STEM<\/h4>\n

ver m\u00e1s<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_custom_heading text=”News” font_container=”tag:h2|font_size:35|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1638395476420{margin-top: 1px !important;padding-top: 10px !important;}”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”4058″ img_size=”720×720″ alignment=”center” css=”” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”UDIBI at the Festival of Biologics 2024, Basel Switzerland” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=””][vc_column_text css=””]On October 16, Dr. Juan Carlos Almagro, Director of Antibody Research at UDIBI, participated in the \u201cFestival of Biologics 2024\u201d in Basel, Switzerland. This event gathered international experts to advance […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"pmpro_default_level":"","footnotes":""},"class_list":["post-1657","page","type-page","status-publish","hentry","pmpro-has-access"],"yoast_head":"\nNews - UDIBI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udibi.com.mx\/en\/news\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News - UDIBI\" \/>\n<meta property=\"og:description\" content=\"[vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_custom_heading text=”News” font_container=”tag:h2|font_size:35|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1638395476420{margin-top: 1px !important;padding-top: 10px !important;}”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”4058″ img_size=”720×720″ alignment=”center” css=”” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”UDIBI at the Festival of Biologics 2024, Basel Switzerland” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=””][vc_column_text css=””]On October 16, Dr. Juan Carlos Almagro, Director of Antibody Research at UDIBI, participated in the \u201cFestival of Biologics 2024\u201d in Basel, Switzerland. This event gathered international experts to advance […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udibi.com.mx\/en\/news\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIBI\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-17T15:27:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"23 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udibi.com.mx\/en\/news\/\",\"url\":\"https:\/\/udibi.com.mx\/en\/news\/\",\"name\":\"News - UDIBI\",\"isPartOf\":{\"@id\":\"https:\/\/udibi.com.mx\/en\/#website\"},\"datePublished\":\"2022-01-13T21:30:46+00:00\",\"dateModified\":\"2024-10-17T15:27:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/udibi.com.mx\/en\/news\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udibi.com.mx\/en\/news\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udibi.com.mx\/en\/news\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/udibi.com.mx\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udibi.com.mx\/en\/#website\",\"url\":\"https:\/\/udibi.com.mx\/en\/\",\"name\":\"UDIBI\",\"description\":\"IPN\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udibi.com.mx\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News - UDIBI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udibi.com.mx\/en\/news\/","og_locale":"en_US","og_type":"article","og_title":"News - UDIBI","og_description":"[vc_row padding_top=”10″ padding_bottom=”10″][vc_column][vc_custom_heading text=”News” font_container=”tag:h2|font_size:35|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=”.vc_custom_1638395476420{margin-top: 1px !important;padding-top: 10px !important;}”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/4″][vc_single_image image=”4058″ img_size=”720×720″ alignment=”center” css=”” full_width=”yes”][\/vc_column][vc_column width=”3\/4″][vc_custom_heading text=”UDIBI at the Festival of Biologics 2024, Basel Switzerland” font_container=”tag:h3|font_size:22|text_align:left|color:%230d1250″ google_fonts=”font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal” css=””][vc_column_text css=””]On October 16, Dr. Juan Carlos Almagro, Director of Antibody Research at UDIBI, participated in the \u201cFestival of Biologics 2024\u201d in Basel, Switzerland. This event gathered international experts to advance […]","og_url":"https:\/\/udibi.com.mx\/en\/news\/","og_site_name":"UDIBI","article_modified_time":"2024-10-17T15:27:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"23 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/udibi.com.mx\/en\/news\/","url":"https:\/\/udibi.com.mx\/en\/news\/","name":"News - UDIBI","isPartOf":{"@id":"https:\/\/udibi.com.mx\/en\/#website"},"datePublished":"2022-01-13T21:30:46+00:00","dateModified":"2024-10-17T15:27:51+00:00","breadcrumb":{"@id":"https:\/\/udibi.com.mx\/en\/news\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udibi.com.mx\/en\/news\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/udibi.com.mx\/en\/news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/udibi.com.mx\/en\/"},{"@type":"ListItem","position":2,"name":"News"}]},{"@type":"WebSite","@id":"https:\/\/udibi.com.mx\/en\/#website","url":"https:\/\/udibi.com.mx\/en\/","name":"UDIBI","description":"IPN","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udibi.com.mx\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/1657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/comments?post=1657"}],"version-history":[{"count":40,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/1657\/revisions"}],"predecessor-version":[{"id":4060,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/1657\/revisions\/4060"}],"wp:attachment":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/media?parent=1657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}